$MLSS
MILESTONE SCIENTIFIC INC.

2021 Q2 Form 10-Q Financial Statement

#000143774921019885 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 Q1 2020 Q2
Revenue $2.426M $2.925M $167.7K
YoY Change 1346.7% 61.46% -92.57%
Cost Of Revenue $1.056M $1.122M $55.63K
YoY Change 1799.08% 112.88% -92.6%
Gross Profit $1.369M $1.802M $112.0K
YoY Change 1122.11% 40.35% -92.56%
Gross Profit Margin 56.45% 61.62% 66.82%
Selling, General & Admin $4.012M $2.749M $3.156M
YoY Change 27.13% 0.05% 25.32%
% of Gross Profit 292.96% 152.54% 2816.32%
Research & Development $215.4K $16.44K $108.2K
YoY Change 99.15% -84.7% 13.23%
% of Gross Profit 15.73% 0.91% 96.54%
Depreciation & Amortization $14.83K $20.92K $21.14K
YoY Change -29.82% -43.78% -16.96%
% of Gross Profit 1.08% 1.16% 18.87%
Operating Expenses $4.242M $2.787M $3.285M
YoY Change 29.13% -3.67% 25.69%
Operating Profit -$2.873M -$984.4K -$3.173M
YoY Change -9.47% -38.81% 186.41%
Interest Expense -$4.460K -$2.540K -$4.060K
YoY Change 9.85% -2409.09% -132.09%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.601M -$986.9K -$3.177M
YoY Change -18.13% -38.8% 189.41%
Income Tax $83.00 $250.00 $1.250K
% Of Pretax Income
Net Earnings -$2.680M -$972.9K -$3.166M
YoY Change -15.35% -39.2% 204.09%
Net Earnings / Revenue -110.5% -33.26% -1888.46%
Basic Earnings Per Share -$0.04 -$0.01 -$0.06
Diluted Earnings Per Share -$0.04 -$0.01 -$0.06
COMMON SHARES
Basic Shares Outstanding 69.22M 66.58M 56.69M
Diluted Shares Outstanding 69.22M 66.58M 56.69M

Balance Sheet

Concept 2021 Q2 2021 Q1 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.98M $16.95M $16.61M
YoY Change -3.81% 2112.94% 610.57%
Cash & Equivalents $16.00M $16.95M $16.61M
Short-Term Investments
Other Short-Term Assets $442.3K $688.8K $468.9K
YoY Change -5.68% -2.57% -6.1%
Inventory $1.479M $2.021M $1.852M
Prepaid Expenses
Receivables $812.3K $978.8K $107.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $20.11M $21.66M $19.88M
YoY Change 1.13% 311.68% 215.75%
LONG-TERM ASSETS
Property, Plant & Equipment $30.75K $27.07K $30.93K
YoY Change -0.57% -9.64% -52.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $24.15K $24.15K $24.15K
YoY Change 0.0% 0.0% 39.15%
Total Long-Term Assets $954.5K $981.7K $1.083M
YoY Change -11.84% -11.83% 120.14%
TOTAL ASSETS
Total Short-Term Assets $20.11M $21.66M $19.88M
Total Long-Term Assets $954.5K $981.7K $1.083M
Total Assets $21.06M $22.64M $20.96M
YoY Change 0.46% 255.18% 208.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $582.7K $694.0K $461.5K
YoY Change 26.25% -51.93% -61.31%
Accrued Expenses $1.391M $1.179M $1.048M
YoY Change 32.69% 41.64% -28.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $276.2K $272.1K
YoY Change -100.0%
Long-Term Debt Due $8.160K $7.980K $6.110K
YoY Change 33.55%
Total Short-Term Liabilities $2.949M $3.039M $3.368M
YoY Change -12.45% -42.01% -43.4%
LONG-TERM LIABILITIES
Long-Term Debt $24.43K $26.54K $32.60K
YoY Change -25.06% -23.12%
Other Long-Term Liabilities $518.4K $538.4K $594.4K
YoY Change -12.79% -12.03%
Total Long-Term Liabilities $542.8K $565.0K $627.0K
YoY Change -13.43% -12.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.949M $3.039M $3.368M
Total Long-Term Liabilities $542.8K $565.0K $627.0K
Total Liabilities $3.491M $3.604M $3.995M
YoY Change -12.61% -38.78% -32.87%
SHAREHOLDERS EQUITY
Retained Earnings -$104.5M -$101.9M -$98.32M
YoY Change 6.33% 7.08% 11.95%
Common Stock $123.1M $121.9M $116.3M
YoY Change 5.92% 26.2% 29.75%
Preferred Stock
YoY Change
Treasury Stock (at cost) $911.5K $911.5K $911.5K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $33.33K $33.33K $33.33K
Shareholders Equity $17.69M $19.14M $17.04M
YoY Change
Total Liabilities & Shareholders Equity $21.06M $22.64M $20.96M
YoY Change 0.46% 255.18% 208.82%

Cashflow Statement

Concept 2021 Q2 2021 Q1 2020 Q2
OPERATING ACTIVITIES
Net Income -$2.680M -$972.9K -$3.166M
YoY Change -15.35% -39.2% 204.09%
Depreciation, Depletion And Amortization $14.83K $20.92K $21.14K
YoY Change -29.82% -43.78% -16.96%
Cash From Operating Activities -$1.103M -$967.8K -$3.139M
YoY Change -64.88% -0.44% 680.74%
INVESTING ACTIVITIES
Capital Expenditures -$7.160K $5.916K -$8.360K
YoY Change -14.35% -17.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$7.160K -$5.916K -$8.360K
YoY Change -14.35% -17.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 136.3K $3.701M 18.99M
YoY Change -99.28% 1516.51%
NET CHANGE
Cash From Operating Activities -1.103M -$967.8K -3.139M
Cash From Investing Activities -7.160K -$5.916K -8.360K
Cash From Financing Activities 136.3K $3.701M 18.99M
Net Change In Cash -973.4K $2.727M 15.84M
YoY Change -106.14% -463.43% -4040.28%
FREE CASH FLOW
Cash From Operating Activities -$1.103M -$967.8K -$3.139M
Capital Expenditures -$7.160K $5.916K -$8.360K
Free Cash Flow -$1.095M -$973.7K -$3.131M
YoY Change -65.02% -0.56% 678.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67166428
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67055869
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67022536
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64171435
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64138102
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
33333
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
33333
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1628647 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-3178202 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16968589 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
us-gaap Open Tax Year
OpenTaxYear
2017 2018 2019
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15977330 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14223917 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
812341 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1080656 USD
CY2021Q2 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
0 USD
CY2020Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
0 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
442295 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
415915 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
1479391 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2420179 USD
CY2021Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
1393817 USD
CY2020Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
414202 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
20105174 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
18554869 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30749 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30729 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
306544 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
329249 USD
CY2021Q2 mlss Lease Rightofuse Asset
LeaseRightofuseAsset
593049 USD
CY2020Q4 mlss Lease Rightofuse Asset
LeaseRightofuseAsset
632453 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24150 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24150 USD
CY2021Q2 us-gaap Assets
Assets
21059666 USD
CY2020Q4 us-gaap Assets
Assets
19571450 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
582684 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
482972 USD
CY2021Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
201887 USD
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
385138 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1390560 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
824454 USD
CY2021Q2 mlss Accrued Expenses Related Party
AccruedExpensesRelatedParty
352209 USD
CY2020Q4 mlss Accrued Expenses Related Party
AccruedExpensesRelatedParty
586734 USD
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8162 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7796 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
76008 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72031 USD
CY2021Q2 mlss Deferred Profit Related Parties Current
DeferredProfitRelatedPartiesCurrent
337145 USD
CY2020Q4 mlss Deferred Profit Related Parties Current
DeferredProfitRelatedPartiesCurrent
242589 USD
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
276180 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2948655 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2877894 USD
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
24433 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
28607 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
518408 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
557981 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
55626 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2178797 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
615326 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
1369354 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
112048 USD
us-gaap Gross Profit
GrossProfit
3171648 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
231864 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
54457 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
4241926 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
3284938 USD
us-gaap Operating Expenses
OperatingExpenses
7028593 USD
us-gaap Operating Expenses
OperatingExpenses
6145230 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2872572 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3172890 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3856945 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4781496 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21059666 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19571450 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2425738 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
167674 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5350445 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1979060 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1056384 USD
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4461 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4062 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6996 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8159 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
276180 USD
CY2021Q2 us-gaap Liabilities
Liabilities
3491496 USD
CY2020Q4 us-gaap Liabilities
Liabilities
3464482 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
67055 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
64171 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
123075664 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
117934696 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104539294 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100885957 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
911516 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
911516 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
17691909 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
16201394 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
-123739 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-94426 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17568170 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16106968 USD
us-gaap Gross Profit
GrossProfit
1363734 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4011672 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3155630 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6760969 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5875123 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14834 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108170 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35760 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
215650 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
215420 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21138 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-94556 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-2696793 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-3178202 USD
us-gaap Profit Loss
ProfitLoss
-3682650 USD
us-gaap Profit Loss
ProfitLoss
-4791155 USD
CY2021Q1 mlss Stock To Be Issued During Period Value Employee Bonuses
StockToBeIssuedDuringPeriodValueEmployeeBonuses
100000 USD
CY2021Q1 mlss Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
3012216 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-985857 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-16325 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11738 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-29313 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-24476 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2680468 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3166464 USD
us-gaap Net Income Loss
NetIncomeLoss
-3653337 USD
us-gaap Net Income Loss
NetIncomeLoss
-4766679 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19037089 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
276180 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2600853 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3176952 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3587761 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4789655 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1250 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
333 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500 USD
CY2021Q2 mlss Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2600936 USD
CY2020Q2 mlss Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3178202 USD
mlss Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3588094 USD
mlss Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4791155 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-95857 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69220795
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56694793
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68286033
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51728806
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69220795
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56694793
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68286033
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51728806
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16106968 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113507 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
690190 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
193824 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15000 USD
CY2021Q2 mlss Stock To Be Issued During Period Value Issued For Services
StockToBeIssuedDuringPeriodValueIssuedForServices
262683 USD
CY2021Q2 mlss Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
138200 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-2696793 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17568170 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30715 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15012 USD
CY2020Q1 mlss Stock To Be Issued During Period Value Employee Bonuses
StockToBeIssuedDuringPeriodValueEmployeeBonuses
171046 USD
CY2020Q1 mlss Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
230362 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-1612953 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
487829 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23946 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15000 USD
CY2020Q2 mlss Stock Issued During Period Value Employee Bonuses
StockIssuedDuringPeriodValueEmployeeBonuses
0 USD
CY2020Q2 mlss Stock To Be Issued During Period Value Employee Bonuses
StockToBeIssuedDuringPeriodValueEmployeeBonuses
462504 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4626442 USD
CY2020Q2 mlss Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
718650 USD
us-gaap Profit Loss
ProfitLoss
-3682650 USD
us-gaap Profit Loss
ProfitLoss
-4791155 USD
us-gaap Depreciation
Depreciation
13055 USD
us-gaap Depreciation
Depreciation
31851 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22705 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26506 USD
us-gaap Share Based Compensation
ShareBasedCompensation
307331 USD
us-gaap Share Based Compensation
ShareBasedCompensation
58219 USD
mlss Sharebased Compensation Bonus Paid In Stock
SharebasedCompensationBonusPaidInStock
748171 USD
mlss Sharebased Compensation Bonus Paid In Stock
SharebasedCompensationBonusPaidInStock
714005 USD
mlss Expenses Paid Stock
ExpensesPaidStock
262713 USD
mlss Expenses Paid Stock
ExpensesPaidStock
406800 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-94556 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-0 USD
mlss Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
3808 USD
mlss Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
28901 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
276180 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-268315 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1603379 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-0 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-0 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-0 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-11755 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-940788 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
231944 USD
mlss Increase Decrease To Advances To Contract Manufacturer
IncreaseDecreaseToAdvancesToContractManufacturer
979615 USD
mlss Increase Decrease To Advances To Contract Manufacturer
IncreaseDecreaseToAdvancesToContractManufacturer
131518 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26380 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-50162 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-99713 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
917898 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-183251 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-839359 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
551136 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
272953 USD
mlss Increase Decrease In Accrued Liabilities Related Parties
IncreaseDecreaseInAccruedLiabilitiesRelatedParties
-234525 USD
mlss Increase Decrease In Accrued Liabilities Related Parties
IncreaseDecreaseInAccruedLiabilitiesRelatedParties
-404161 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
949012 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3808 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3200 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
690190 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2070310 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4111504 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13075 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15499 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13075 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15499 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3150416 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
272099 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18003037 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3836798 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19220948 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1753413 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15093945 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14223917 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1516272 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15977330 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16610217 USD
mlss Operating Lease Right Of Use Asset Incurred
OperatingLeaseRightOfUseAssetIncurred
0 USD
mlss Operating Lease Right Of Use Asset Incurred
OperatingLeaseRightOfUseAssetIncurred
-706071 USD
mlss Operating Lease Right Of Use Liability
OperatingLeaseRightOfUseLiability
0 USD
mlss Operating Lease Right Of Use Liability
OperatingLeaseRightOfUseLiability
706071 USD
CY2021Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
60 pure
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1800000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104539294 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2700000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3700000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1800000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b><em style="font: inherit;">3.</em>  Reclassifications</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b> </b></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Certain reclassification has been made to the <em style="font: inherit;">2020</em> unaudited condensed consolidated financial statements to conform to the <em style="font: inherit;">2021</em> unaudited condensed consolidated financial statement presentation. These reclassifications had <em style="font: inherit;">no</em> effect on net loss or cash flows as previously reported.</p>
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
1479391 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b><em style="font: inherit;">4.</em>  Use of Estimates</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates.</p>
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
14800000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
13100000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
280864 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 USD
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
450000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
453000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
181324 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
331711 USD
CY2021Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
1393817 USD
CY2020Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
414202 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2420179 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1377863 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1071319 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
306544 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1377863 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1048614 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
329249 USD
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6369396
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.97
CY2020 mlss Warrants And Rights Outstanding Weighted Average Remaining Term
WarrantsAndRightsOutstandingWeightedAverageRemainingTerm
P2Y5M23D
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2784117 USD
mlss Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
0
mlss Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
mlss Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
2004926
mlss Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
1.57
mlss Class Of Warrant Or Right Expired Or Cancelled During Period
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
-0
mlss Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
0
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4364470
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.15
mlss Warrants And Rights Outstanding Weighted Average Remaining Term
WarrantsAndRightsOutstandingWeightedAverageRemainingTerm
P2Y3D
CY2021Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1796413 USD
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1074171
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
CY2019 mlss Warrants And Rights Outstanding Weighted Average Remaining Term
WarrantsAndRightsOutstandingWeightedAverageRemainingTerm
P4Y1M6D
CY2019Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
956012 USD
mlss Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
6459000
mlss Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
2.01
mlss Warrants And Rights Issued Weighted Average Remaining Term
WarrantsAndRightsIssuedWeightedAverageRemainingTerm
P3Y
mlss Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
1081475
mlss Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
0.88
mlss Class Of Warrant Or Right Expired Or Cancelled During Period
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
-0
mlss Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
0
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6451696
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.95
mlss Warrants And Rights Outstanding Weighted Average Remaining Term
WarrantsAndRightsOutstandingWeightedAverageRemainingTerm
P2Y11M23D
CY2020Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2430184 USD
CY2020Q4 us-gaap Deferred Compensation Arrangement With Individual Shares Authorized For Issuance
DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance
2428329
CY2019Q4 us-gaap Deferred Compensation Arrangement With Individual Shares Authorized For Issuance
DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance
2375760
mlss Deferred Compensation Arrangement With Individual Shares Granted
DeferredCompensationArrangementWithIndividualSharesGranted
33238
mlss Deferred Compensation Arrangement With Individual Shares Granted
DeferredCompensationArrangementWithIndividualSharesGranted
358482
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
53416
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
214612
CY2021Q2 us-gaap Deferred Compensation Arrangement With Individual Shares Authorized For Issuance
DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance
2408151
CY2020Q2 us-gaap Deferred Compensation Arrangement With Individual Shares Authorized For Issuance
DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance
2519630
mlss Percentage Of Valuation Allowance
PercentageOfValuationAllowance
1 pure
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2425738 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2872572 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
167674 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5350445 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1979060 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3172890 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3856945 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4781496 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14834 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21138 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35760 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54457 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2600853 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3176952 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3587761 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4789655 USD
CY2021Q2 us-gaap Assets
Assets
21059666 USD
CY2020Q4 us-gaap Assets
Assets
19571450 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2425738 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
167674 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5350445 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1979060 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
593049 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
594416 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
76008 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
518408 USD
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
32595 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8162 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
24433 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
597770 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
630012 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72031 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
557981 USD
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
36403 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7796 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
28607 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
31303 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
30820 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
62606 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
48084 USD
CY2021Q2 mlss Finance Lease Principal Payments Including Accrued Expenses
FinanceLeasePrincipalPaymentsIncludingAccruedExpenses
2685 USD
CY2020Q2 mlss Finance Lease Principal Payments Including Accrued Expenses
FinanceLeasePrincipalPaymentsIncludingAccruedExpenses
2685 USD
mlss Finance Lease Principal Payments Including Accrued Expenses
FinanceLeasePrincipalPaymentsIncludingAccruedExpenses
5370 USD
mlss Finance Lease Principal Payments Including Accrued Expenses
FinanceLeasePrincipalPaymentsIncludingAccruedExpenses
4937 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
663009 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
43242 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y9M18D
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2005Q1 mlss Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology
AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology
0.025 pure
CY2005Q1 mlss Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology
AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology
0.05 pure

Files In Submission

Name View Source Status
0001437749-21-019885-index-headers.html Edgar Link pending
0001437749-21-019885-index.html Edgar Link pending
0001437749-21-019885.txt Edgar Link pending
0001437749-21-019885-xbrl.zip Edgar Link pending
ex_258241.htm Edgar Link pending
ex_258242.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlss-20210630.xsd Edgar Link pending
mlss-20210630_cal.xml Edgar Link unprocessable
mlss-20210630_def.xml Edgar Link unprocessable
mlss-20210630_lab.xml Edgar Link unprocessable
mlss-20210630_pre.xml Edgar Link unprocessable
mlss20210630_10q.htm Edgar Link pending
mlss20210630_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending